日本語 ／ English
NEWS
Notice of article in Nikkei Biotech regarding the development of our ligands
Poster presentation at the 10th Annual Meeting of Nucleic Acids Therapeutics Society of Japan
HDO(Hetero-Duplex Oligonucleotide) Trial Campaign Announcement
Announcement on Completion of signing additional license agreement with Takeda Pharmaceutical Company Limited
Japan Healthcare Venture Summit 2024
BIO International Convention 2024
Japan Healthcare Venture Summit 2023
Announcement on Completion of signing additional license agreement with Takeda Pharmaceutical Co., Ltd.
Representative Director/CEO Mr.Toriya gave a lecture at the Symposium of the 143rd Annual Meeting of the Pharmaceutical Society of Japan on March 28, 2023
Announcement on Completion of signing license agreement with NIPPON SHOKUBAI Co., Ltd..
Announcement on Completion of signing license agreement with Nippon Gene Material Co., Ltd.
Japan Healthcare Venture Summit 2022
